Cryptococcus neoformans infection.
Paterson
David L
DL
VA Medical Center and the University of Pittsburgh, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA.
Singh
Nina
N
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003453:Cryptococcosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003840:Deoxycholic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016377:Organ Transplantation / Q000009:adverse effects*
D000935:Antifungal Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination; D015725:Fluconazole; D005437:Flucytosine